| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Joan M Neuner | |
| Ann B Nattinger | |||
| Alda Maria Gonzaga | |||
| Jennifer R Zebrack | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Q28283241 | ||
| Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP) | Q28294460 | ||
| Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial | Q29615226 | ||
| Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review | Q33251613 | ||
| ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions | Q34532539 | ||
| Sexually transmitted diseases treatment guidelines, 2006. | Q34554277 | ||
| Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update | Q34575872 | ||
| Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review | Q35739980 | ||
| ACOG Committee Opinion. Evaluation and management of abnormal cervical cytology and histology in the adolescent. Number 330, April 2006. | Q36438420 | ||
| Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial | Q39651148 | ||
| Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine | Q44677767 | ||
| Ten years' experience with alendronate for osteoporosis in postmenopausal women | Q44804093 | ||
| National trends in osteoporosis visits and osteoporosis treatment, 1988-2003. | Q44995428 | ||
| ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis. | Q51807804 | ||
| Pharmacokinetics of alendronate: an overview | Q73202765 | ||
| Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial | Q73365346 | ||
| Prospective breast cancer risk prediction model for women undergoing screening mammography | Q80216670 | ||
| Osteonecrosis of the jaw: more research needed | Q80331532 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 93-99 | |
| P577 | publication date | 2007-11-28 | |
| P1433 | published in | Journal of General Internal Medicine | Q6295242 |
| P1476 | title | Update in women's health 2006-2007. | |
| P478 | volume | 23 |
Search more.